S'abonner

Intensive interdisciplinary specialized rehabilitation or regular physiotherapy for multiple sclerosis? A randomised controlled trial with economic evaluation - 24/03/25

Doi : 10.1016/j.rehab.2024.101898 
C Bonnyaud a, b, , S Hameau c, d, R Zory e, f, M Sznajder g, O Heinzlef h, i, C Aymard j, A Chenet k, B Médée l, M Jacota g, P Gallien m, D Bensmail n, o

Rehabmuscle Team

N Derridj g, I Sanogo g, M Fournier Mehouas p, A Blanchard-Dauphin q
g Clinical Research Unit, Ambroise Paré hospital, GHU Paris Saclay, APHP, 9 Av. Charles de Gaulle 92100 Boulogne-Billancourt, Boulogne, France 
p Archet hospital, CHU, 1BP 3079 06202, Nice, France 
q Pierre Swynghedauw Hospital, CHRU, Rue André Verhaeghe, Lille, France 

a Motion analysis laboratory, Functional Exploration Department, Raymond Poincaré Hospital, GHU Paris Saclay, APHP, 104 Bld Raymond Poincaré, Garches, France 
b Paris-Saclay University, UVSQ, Research Unit ERPHAN, 104 Bld Raymond Poincaré, Versailles, France 
c Inserm, Clinical Investigation Center (CIC 1414), University Hospital Center, Rennes, France 
d Physical and Rehabilitation medicine Department, University Hospital Center, 2 Rue Henri le Guilloux, Rennes, France 
e Université Côte d'Azur, LAMHESS, Bld du Mercantour B.P., Nice, France 
f Institut universitaire de France, 1 rue Descartes Paris, France 
g Clinical Research Unit, Ambroise Paré hospital, GHU Paris Saclay, APHP, 9 Av. Charles de Gaulle 92100 Boulogne-Billancourt, Boulogne, France 
h Department of Neurology, Poissy-Saint-Germain-en-Laye Hospital, 10 rue Champ Gaillard, Poissy, France 
i CRC SEP IDF Ouest, 104 Bld Raymond Poincaré 92380 Garches / 10 rue Champ Gaillard, Poissy-Garches, France 
j Physical and Rehabilitation medicine Department, Fondation hospitalière Sainte-Marie, 167 rue Raymond Losserand, Paris, France 
k Physical and Rehabilitation medicine Department, University Hospital Nantes, 85 Rue Saint-Jacques 44093 Nantes, France 
l Physical medicine and rehabilitation department, CHRU Brest, France, 2 avenue Foch 29609 Brest 
m Pole Saint Hélier, 54 Rue Saint-Hélier, Rennes, France 
n Physical and Rehabilitation medicine Department, Raymond Poincaré Hospital, GHU Paris Saclay, APHP, 104 Bld Raymond Poincaré, Garches, France 
o End: icap laboratory, Inserm Unit 1179, UVSQ, 2 Av. de la Source de la Bièvre, Montigny-le-Bretonneux, France 

Corresponding author.

Highlights

IROSU is interdisciplinary rehabilitation in an outpatient specialised unit.
Strength and quality of life improve more with IROSU than community physiotherapy.
The sensitivity of the 6-minute walk test is low.
Improvements after a short rehabilitation program are maintained at 5 months.
Cost-utility is in favour of the interdisciplinary specialised program.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

The benefits of Interdisciplinary Rehabilitation in an Outpatient Specialised Unit (IROSU) have not been determined.

Objectives

To compare the effects of IROSU and physiotherapy in the community on impairment, function and Quality Of Life (QoL) in people with Multiple Sclerosis (pwMS) and to determine the medico-economic impact.

Methods

Pragmatic, multicentre, parallel, randomized (centralised computer-generated randomisation) controlled trial. 148 pwMS were analysed (73 in the IROSU group, 75 in the community group). IROSU included balance, stretching, walking, resistance and endurance training. The 6-Minute Walk Test (6MWT) was the primary outcome. Secondary outcomes were speed over 10 m, Timed Up and Go and Stair test, balance (Berg Balance Scale, posturology), knee extensor and flexor strength (isokinetic dynamometer), peak power output (cycling test), fatigue (Fatigue Severity Scale, Modified Fatigue Impact Scale), QoL (EuroQol EQ5D3 L, SEP59), anxiety and depression (Hospital Anxiety and Depression scale) and Multiple Sclerosis Impact Scale. Evaluations were performed before, after 4 weeks of training and 3 and 6 months after the start by therapists blinded to group allocation. Linear mixed effect models were used (intention-to-treat analysis). Cost-effectiveness and cost-utility ratios were analysed.

Results

6MWT increased similarly in both groups from baseline to M1 (423.8 (126.7) m to 476.0 (119) m IROSU, 404.4 (99.3) m to 440.5 (112.1) m community, P < 0.001), to M3 (P < 0.001) and to M6 (P = 0.001). Knee extensor strength, power output and QoL-physical health improved significantly more in IROSU group (P < 0.05, effect size 0.25–0.61). Many improvements were maintained at the 6-month follow-up. Gain in quality adjusted life years and cost-utility ratios were in favour of IROSU.

Conclusions

Walking distance improved similarly in both groups but this was underpowered. The larger improvements in secondary outcomes and quality-adjusted life years after IROSU, maintained at the 6-month follow-up, suggest pwMS should have access to this program each year.

Trial registration Clinical Trials

NCT01871818.

Le texte complet de cet article est disponible en PDF.

Keywords : Multiple sclerosis, Interdisciplinary rehabilitation, Specialised unit, Community, Follow-up, Strength, Quality of life

Abbreviations : 6mwt, 10mwt, bbs, edss, eq-5d-3L, fss, had, hrqol, irosu, m1, m3 and m6, mfis, ms, msis-29, MSQoL-54, NMB, pwMS, QALY, QoL, RPE


Plan


© 2024  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 68 - N° 2

Article 101898- mars 2025 Retour au numéro
Article précédent Article précédent
  • Nitrous oxide analgesia for rehabilitation after anterior cruciate ligament reconstruction: A randomized controlled trial
  • Ziyang Wang, Lingjun Zhou, Fei Wang, Xiaochen Jiang, Weifeng Wang, Xueling Qiu, Yihui Xing, Chongjian Fu, Ping Zhong, Lu Tang
| Article suivant Article suivant
  • Effects of high-intensity interval training on cardiorespiratory function in coronary artery disease: An overview of systematic reviews
  • Yingtian Yang, Qianyu Lv, Xirui Zhang, Qian Wu, Lanlan Li, Xuejiao Ye, Shihan Wang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.